Compound information
- Natural Products
- ZC3407595
- Molecular Formula
- C31H28ClN7O2
- Molecular Weight
- 565.199300816 g/mol
- Structure
-
- IUPAC Name
- N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]-3-[[(E)-4-(dimethylamino)but-2-enoyl]amino]benzamide
- InChI
- InChI=1S/C31H28ClN7O2/c1-39(2)15-7-14-28(40)35-21-9-5-8-20(16-21)30(41)36-22-10-6-11-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-13-4-3-12-24(25)27/h3-14,16-19,33H,15H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b14-7+
- InChI Key
- FONRCZUZCHXWBD-VGOFMYFVSA-N
- SMILES
- CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1
- Source
- ZINC000214463223
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 41 | Ring Count | 5 |
Heteroatom Count | 10 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 115.04 Å2 | LogP | 5.025 |
LogS | -6.36 | LogD | 4.231 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.073 | Pgp substrate | 0.237 |
HIA | 0.965 | F20 % | 0.956 |
F30 % | 0.272 | Caco-2 | -5.157 |
MDCK | -5.721 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.001 | PPB | 98.122 |
VD | 1.24 | Fu | 1.914 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.999 | CYP1A2 substrate | 0.758 |
CYP2A6 substrate | 0.251 | CYP2B6 substrate | 0.656 |
CYP2C19 inhibitor | 0.221 | CYP2C19 substrate | 0.858 |
CYP2C8 substrate | 0.919 | CYP2C9 inhibitor | 0.138 |
CYP2C9 substrate | 0.441 | CYP2D6 inhibitor | 0.893 |
CYP2D6 substrate | 0.945 | CYP2E1 substrate | 0.246 |
CYP3A4 inhibitor | 0.892 | CYP3A4 substrate | 0.994 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.386 | CL | 4.714 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.181 | Hepatotoxicity | 0.971 |
Mutagenicity | 0.084 | Rat Oral Acute Toxicity | 0.006 |
FDAMDD | 0.942 | Skin Sensitization | 0.546 |
Carcinogenicity | 0.056 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.944 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.705 | IGC50 | 4.886 |
LC50FM | -5.11 | LC50DM | 1.669 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.278 | NR-AR-LBD | 0.518 |
NR-AhR | 0.994 | NR-Aromatase | 0.801 |
NR-ER | 0.822 | NR-ER-LBD | 0.68 |
NR-PPAR-gamma | 0.944 | SR-ARE | 0.956 |
SR-ATAD5 | 0.851 | SR-HSE | 0.826 |
SR-MMP | 0.956 | SR-p53 | 0.951 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.